Pharbest Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Pharbest Pharmaceuticals's estimated annual revenue is currently $8M per year.
- Pharbest Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Pharbest Pharmaceuticals has 40 Employees.
- Pharbest Pharmaceuticals grew their employee count by 5% last year.
Pharbest Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Procurement and Inventory Manager | Reveal Email/Phone |
2 | Inventory Manager and Account Specialist | Reveal Email/Phone |
3 | QA Manager | Reveal Email/Phone |
4 | Product Development and Product Management Incharge | Reveal Email/Phone |
5 | Market Research and Business Development Associate | Reveal Email/Phone |
6 | Marketing Associate | Reveal Email/Phone |
Pharbest Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13.1M | 65 | 7% | N/A | N/A |
#2 | $354.3M | 484 | -2% | $567.1M | N/A |
#3 | $347.1M | 1727 | -8% | N/A | N/A |
#4 | $8.8M | 44 | 13% | N/A | N/A |
#5 | $6M | 30 | 11% | N/A | N/A |
#6 | $46.6M | 232 | 4% | N/A | N/A |
#7 | $6.6M | 33 | -3% | N/A | N/A |
#8 | $11.3M | 56 | 12% | N/A | N/A |
#9 | $168.8M | 840 | 46% | N/A | N/A |
#10 | $12.3M | 61 | -21% | N/A | N/A |
What Is Pharbest Pharmaceuticals?
OTC/GENERIC manufacturer specializing in production and packaging of OTC and NEUTRACEUTICAL finished products such as Regular Aspirin, Low-Dose Aspirin, Enteric Coated Aspirin, Acetaminophen, Diphenhydramine, Oyster Shell Calcium, Senna, Docusate Sodium Soft gelatin capsule, Ibuprofen, Calcium Carbonate, Vitamin C...etc.
keywords:N/AN/A
Total Funding
40
Number of Employees
$8M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.7M | 40 | -2% | N/A |
#2 | $8.1M | 41 | 11% | N/A |
#3 | $9.1M | 42 | -11% | N/A |
#4 | $8.3M | 42 | 8% | N/A |
#5 | $10M | 43 | -2% | N/A |